Devlin Jodi bought TLSI

February 12, 2024 · Form 4 insider transaction

Devlin Jodi bought 17,500 shares of TriSalus Life Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
17,500
Price
$0.00
Total value
N/A
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2024
Filing dateFebruary 14, 2024
Shares owned after17,500
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on February 12, 2024, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

View the original Form 4 on SEC EDGAR